MUFG Americas’s VanEck Biotech ETF BBH Stock Holding History

MUFG Americas’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-30	Closed	-$6K	–	840
2021 Q2	$6K	Hold	30	–	–	﹤0.01%	628
2021 Q1	$5K	Hold	30	–	–	﹤0.01%	645
2020 Q4	$5K	Hold	30	–	–	﹤0.01%	655
2020 Q3	$5K	Buy	+30	New	+$4.88K	﹤0.01%	622

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

MUFG Americas's BBH Position: Q3 2021 in Review

MUFG Americas sold out of VanEck Biotech ETF (BBH) in Q3 2021, closing a stake of 30 shares — an estimated $6K sold.

MUFG Americas first reported a position in BBH in Q3 2020 and held it in 4 quarters. The position peaked at $6K in Q2 2021. 118 funds tracked by Wall St. Rank hold BBH as of Q3 2021.

MUFG Americas reported no remaining VanEck Biotech ETF position as of Q3 2021 after selling out during the quarter.
MUFG Americas sold 30 VanEck Biotech ETF shares in Q3 2021, an estimated $6K.
MUFG Americas first reported a position in VanEck Biotech ETF in Q3 2020 and held it in 4 quarters.
MUFG Americas's VanEck Biotech ETF position peaked at $6K in Q2 2021.
118 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2021.

Based on MUFG Americas's 13F filing for Q3 2021, filed 5 Nov 2021.